Treatment Strategy According to Findings on Pressure-Flow Study for Women with Decreased Urinary Flow Rate

Table 3

Change in parameters after distigmine bromide treatment in patients without bladder outlet obstruction.

Parameters	Pretreatment	Posttreatment	P-value^(1)
Clinical parameters (𝑛=6)
IPSS	17.8 (8.3)^(2)	5.2 (4.8)	.028
QOL index	5.3 (0.5)	1.3 (1.0)	.028
Uroflowmetry
Voided volume (mL)	223.7 (54.6)	245.7 (124.6)	.753
Maximum flow rate (mL/sec)	8.1 (2.3)	13.1 (4.3)	.046
Average flow rate (mL/sec)	3.7 (1.0)	6.8 (1.8)	.028
Postvoid residual urine volume (mL)	71.3 (69.4)	45.0 (61.0)	.249
Pressure flow studies (𝑛=3)
Maximum flow rate (mL/sec)	8.3 (2.9)	13.3 (0.6)	.109
Pressure at maximum flow (cm water)	31.0 (5.6)	33.0 (8.7)	<.999
Urethral resistance factor (cm water)	20.2 (1.3)	15.8 (2.1)	.109
Maximum watts factor (W/m^2)	6.1 (2.5)	8.9 (0.2)	.109

⁽¹⁾Wilcoxon signed-rank test
⁽²⁾Mean (standard deviation).